Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FY9Z3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,414
Award facts
- Contract value 100% obligated
- $15,413.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,413.63 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen auto-injectors on December 2, 2025, with completion scheduled for December 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a specialized biologic medication used to treat moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis, representing the type of specialty pharmaceutical products critical to military and federal healthcare operations.
This delivery order represents a task issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications, biologics, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's significant federal contract portfolio demonstrates its capability to fulfill specialized medical procurement requirements through competitive award processes.
Quick answers
Who was awarded contract SPE2DR26FY9Z3?
SPE2DR26FY9Z3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26FY9Z3 worth?
The government has obligated $15,414 on SPE2DR26FY9Z3.
Is contract SPE2DR26FY9Z3 an order under another contract?
Yes. SPE2DR26FY9Z3 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FY9Z3 competed?
The extent of competition for SPE2DR26FY9Z3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award